152 related articles for article (PubMed ID: 34416800)
1. [Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever].
Karaşahin Ö; Karaşahin EF
Mikrobiyol Bul; 2021 Jul; 55(3):327-341. PubMed ID: 34416800
[TBL] [Abstract][Full Text] [Related]
2. [The Role of Blood Urea Nitrogen and C-Reactive Protein and Their Ratios to Albumin in Predicting Mortality in Crimean-Congo Hemorrhagic Fever].
Karaşahin Ö; İnan Sarıkaya R
Mikrobiyol Bul; 2023 Jul; 57(3):419-431. PubMed ID: 37462305
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the different biomarkers to discriminate bleeding in Crimean-Congo Hemorrhagic Fever.
Büyüktuna SA; Doğan HO; Unlusavuran M; Bakir M
Ticks Tick Borne Dis; 2019 Aug; 10(5):997-1002. PubMed ID: 31151923
[TBL] [Abstract][Full Text] [Related]
4. Resting heart rate in children with Crimean-Congo hemorrhagic fever: a tool to identify patients at risk?
Oflaz MB; Bolat F; Kaya A; Guven AS; Kucukdurmaz Z; Karapinar H; Gulsever O; Dogan M; Cevit O; Icagasioglu FD
Vector Borne Zoonotic Dis; 2014 Jan; 14(1):59-65. PubMed ID: 24359422
[TBL] [Abstract][Full Text] [Related]
5. [A New Score for Predicting Mortality in Crimean-Congo Hemorrhagic Fever Associating CURB-65 with Bleeding: CURB-65+B].
İnan Sarıkaya R; Karaşahin Ö
Mikrobiyol Bul; 2023 Oct; 57(4):553-567. PubMed ID: 37885385
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Simultaneous Acute Lymphoblastic Leukemia Diagnosis with Crimean-Congo Hemorrhagic Fever].
Çayıröz P; Çayıröz MU; Iltar U; Kurtoğlu E
Mikrobiyol Bul; 2020 Apr; 54(2):326-333. PubMed ID: 32723287
[TBL] [Abstract][Full Text] [Related]
8. Crimean-Congo hemorrhagic fever in children.
Tezer H; Sucakli IA; Sayli TR; Celikel E; Yakut I; Kara A; Tunc B; Ergonul O
J Clin Virol; 2010 Jul; 48(3):184-6. PubMed ID: 20444644
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
[TBL] [Abstract][Full Text] [Related]
11. Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever.
Leblebicioglu H; Sunbul M; Barut S; Buyuktuna SA; Ozkurt Z; Yapar D; Yilmaz G; Guner R; But A; Cicek Senturk G; Murat N; Ozaras R;
Antiviral Res; 2016 Sep; 133():9-13. PubMed ID: 27424492
[TBL] [Abstract][Full Text] [Related]
12. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever.
Kaygusuz TÖ; Tartar AS; Balin ŞÖ; Akbulut A; Demirdağ K
Biomark Med; 2023 Jun; 17(11):533-540. PubMed ID: 37791843
[No Abstract] [Full Text] [Related]
13. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
15. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever.
Kilinc C; Gückan R; Capraz M; Varol K; Zengin E; Mengeloglu Z; Menekse E
J Vector Borne Dis; 2016; 53(2):162-7. PubMed ID: 27353587
[TBL] [Abstract][Full Text] [Related]
16. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.
Hasanoglu I; Guner R; Carhan A; Kocak Tufan Z; Yagci-Caglayik D; Guven T; Yilmaz GR; Tasyaran MA
J Clin Virol; 2016 Feb; 75():42-6. PubMed ID: 26780111
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
[TBL] [Abstract][Full Text] [Related]
19. Cytokine release syndrome in Crimean-Congo hemorrhagic fever: can IL-1 receptor antagonist levels be a guide in its treatment?
Çelik N; Laloğlu E
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8934-8942. PubMed ID: 37782202
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of platelet distribution width in patients with Crimean-Congo hemorrhagic fever.
Yilmaz H; Yilmaz G; Menteşe A; Kostakoğlu U; Karahan SC; Köksal İ
J Med Virol; 2016 Nov; 88(11):1862-6. PubMed ID: 27089100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
